Targeted dendrimers

Christine Dufès (Inventor)

Research output: Patent


The present invention relates to a composition for targeted delivery of a bioactive molecule to cells in a body of a recipient, said composition comprising a polypropylenimine dendrimer and/or derivatives thereof to which one or more cell targeting molecule (s) have been conjugated thereto; and a bioactive molecule associated with said polypropylenimine dendrimer and/or derivative thereof. In one embodiment the cells to be targeted are cancer cells. The targeting molecule may be transferrin, lactoferrin, lactoferricin or gambogic acid. There is also provided uses of such compositions, as well as methods of treating diseases, such as cancer.
Original languageEnglish
Patent numberWO 2011/051667 A1
IPCA61K 47/48
Publication statusPublished - 5 May 2011


  • bioactive molecule
  • polypropylenimine dendrimer
  • cell targeting
  • cancer cells


Dive into the research topics of 'Targeted dendrimers'. Together they form a unique fingerprint.

Cite this